CompletedNot Applicable

Mycophenolate Mofetil (MMF) Versus Intravenous CTX Pulses in the Treatment of Adult Severe HSPN

China60 participantsStarted 2003-01

Plain-language summary

This study is performed to compare the efficacy, safety, tolerability and relapse of MMF vs CTX in the treatment of severe HSPN

Who can participate

Age range16 Years – 50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 16-50 years * Biopsy proved HSP * Proteinuria ≥ 3.0 g/24hr * Scr \< 5.0 mg/dl Exclusion Criteria: * Cytotoxic drug treatment such as CTX, CsA, MMF for morn than 1 month-3 months prior to enrolled * Pregnancy * Active/serious infections * Previous diagnosed diabetes mellitus type 1 or 2

What they're measuring

To compare the efficacy,safety, tolerability and relapse of MMF vs CTX in the treatment of severe HSPN

Timeframe: 12 months

Trial details

NCT IDNCT00301613

SponsorNanjing University School of Medicine

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2005-05

View on ClinicalTrials.gov More Henoch-Schoenlein Purpura trials